Streetbeat News

Products Services

ACB

FLGC

TLRY

Flora Growth Corp. (NASDAQ:FLGC) has listed its shares on the Frankfurt Stock Exchange to attract European investors and increase trading liquidity. This move follows Flora's acquisition of Australian Vaporizers Pty Ltd. Additionally, Tilray Brands (NASDAQ:TLRY) and Aurora Cannabis (NASDAQ:ACB) have received cannabis cultivation licenses in Germany under the new Cannabis Act. Flora Growth shares closed 7.68% lower at $0.8983 per share.

Portfolio Pulse from Nina Zdinjak

August 08, 2024 | 2:23 pm

KSCP

Knightscope, Inc. (NASDAQ:KSCP) has announced two new contracts for its emergency communication systems, including a K1 Call Box and Full-Service Maintenance Plan for a Colorado ski resort. The initial installation will be used to gauge future expansion.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:09 pm

LITP

PLL

Piedmont Lithium Inc. (NASDAQ:PLL) reported Q2 FY24 results that missed expectations, with revenue of $13.23 million against a consensus of $18.15 million. The company also reported an adjusted EPS loss of $0.65, missing the consensus loss of $0.26. Despite increased production and higher realized prices for spodumene concentrate, the stock is trading lower. The company is focusing on its Carolina Lithium project and expects steady production in the second half of the year. Investors can also gain exposure through the Sprott Lithium Miners ETF (NASDAQ:LITP).

Portfolio Pulse from Lekha Gupta

August 08, 2024 | 2:09 pm

EWY

NOC

Northrop Grumman (NOC) and Genohco have signed a Memorandum of Understanding (MOU) to collaborate on the Republic of Korea's Mine Countermeasures Helicopter Program. This agreement supports longstanding industrial cooperation with the Defense Acquisition Program Administration.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:57 pm

NVS

The FDA has granted accelerated approval to Novartis AG's (NYSE:NVS) Fabhalta for the treatment of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN). This approval is based on interim results from the Phase 3 APPLAUSE-IgAN study, showing a significant reduction in proteinuria. Continued approval will depend on further clinical benefit verification. Novartis is also developing two additional IgAN therapies.

Portfolio Pulse from Vandana Singh

August 08, 2024 | 1:52 pm

AAPL

AMD

AMZN

ARM

GOOG

META

The article discusses a strategy for navigating current market volatility by hedging existing positions and selectively adding new ones. It highlights successful exits from options trades on Carvana Co. (CVNA) and Meta Platforms, Inc. (META), with gains of 220% and 103% respectively. The author plans to add new positions in oversold stocks with favorable PEG ratios and RSI values, despite cautioning about potential short-term losses if market conditions persist.

Portfolio Pulse from David Pinsen

August 08, 2024 | 1:37 pm

AAPL

BRK.B

FXY

GLD

NVDA

QQQ

SLV

SPY

The article discusses the impact of the Bank of Japan's rate hike on global stocks, particularly through the unwinding of carry trades. This has led to aggressive selling in AI-related semiconductor stocks and the Magnificent Seven stocks. Warren Buffett's Berkshire Hathaway has sold a significant portion of its Apple holdings, increasing its cash position. The article also mentions delays in NVIDIA's next-generation chip and negative money flows in major ETFs and stocks. Investors are advised to consider hedges and protection bands to navigate the current market volatility.

Portfolio Pulse from The Arora Report

August 08, 2024 | 1:37 pm

AAPL

AMZN

GLD

GOOG